Prostaglandin activity in sustained inflammation of human skin before and after aspirin.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D001241:Aspirin / Q000494:pharmacology*; D001920:Bradykinin / Q000032:analysis; D004890:Erythema / Q000139:chemically induced*; D005122:Exudates and Transudates / Q000032:analysis; D005260:Female; D005663:Furans / Q000008:administration & dosage / Q000494:pharmacology*; D006632:Histamine / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis*; D011460:Prostaglandins F / Q000096:biosynthesis; D012867:Skin / Q000032:analysis
D005663:Furans; D009539:Nicotinic Acids; D011453:Prostaglandins; D011460:Prostaglandins F; D006632:Histamine; D001241:Aspirin; D001920:Bradykinin